Selective HAT Inhibitors as Mechanistic Tools for Protein Acetylation

Methods in Enzymology

Volumn 376, Issue , 2003, Pages 188-199

  Zheng, Yujun ^a   Thompson, Paul R ^b   Cebrat, Marek ^a   Wang, Ling ^a   Devlin, Meghann K ^a   Alani, Rhoda M ^a   Cole, Philip A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; DOXORUBICIN; ENZYME INHIBITOR; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE INHIBITOR; HISTONE ACETYLTRANSFERASE PCAF; PROTEIN P53; PROTEIN P73; PROTEIN SWI; SIRTUIN; SMALL INTERFERING RNA; SPHINGOSYLPHOSPHORYLCHOLINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME MECHANISM; FIBROBLAST; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; IC 50; IMMUNOPRECIPITATION; MICROINJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 1042300239     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(03)76012-1     Document Type: Article

References (30)

1. R. Marmorstein, Nat. Rev. Mol. Cell. Biol. 2, 422 (2001).
2. S. L. Schreiber and B. E. Bernstein, Cell 111, 771 (2002).
3. R. L. Strausberg and S. L. Schreiber, Science 300, 294 (2003).
4. M. Yoshida, M. Kijima, M. Akita, and T. Beppu, J. Biol. Chem. 265, 17174 (1990).
5. J. Taunton, C. A. Hassig, and S. L. Schreiber, Science 272, 408 (1996).
6. J. E. Brownell, J. Zhou, T. Ranalli, R. Kobayashi, D. G. Edmondson, S. Y. Roth, and C. D. Allis, Cell 84, 843 (1996).
7. O. D. Lau, T. K. Kundu, R. E. Soccio, S. Ait-Si-Ali, E. M. Khalil, A. Vassilev, A. P. Wolffe, Y. Nakatani, R. G. Roeder, and P. A. Cole, Mol. Cell 5, 589 (2000).
8. W. Zheng and P. A. Cole, Curr. Med. Chem. 9, 1187 (2002).
9. E. M. Khalil, J. De Angelis, M. Ishii, and P. A. Cole, Proc. Natl. Acad. Sci. USA 96, 12418 (1999).
10. A. N. Poux, M. Cebrat, C. M. Kim, P. A. Cole, and R. Marmorstein, Proc. Natl. Acad. Sci. USA 99, 14065 (2002).
11. M. Cebrat, C. M. Kim, P. R. Thompson, M. Daugherty, and P. A. Cole, "Synthesis and Analysis of Potential Prodrugs of Coenzyme A Analogs for the Inhibition of Histone Acetyltransferase p300." Bioorg. Med. Chem. 11, 3307-3313 (2003).
12. A. Polesskaya, I. Naguibneva, A. Duquet, S. Ait-Si-Ali, P. Robin, A. Vervish, P. Cole, and A. Harel-Bellan, EMBO J. 20, 6816 (2001).
13. P. R. Thompson, H. Kurooka, Y. Nakatani, and P. A. Cole, J. Biol. Chem. 276, 33721 (2001).
14. O. D. Lau, A. D. Courtney, A. Vassilev, L. A. Marzilli, R. J. Cotter, Y. Nakatani, and P. A. Cole, J. Biol. Chem. 275, 21953 (2000).
15. K. G. Tanner, M. R. Langer, and J. M. Denu, Biochemistry 39, 11961 (2000).
16. R. C. Trievel, F. Y. Li, and R. Marmorstein, Anal. Biochem. 287, 319 (2000).
17. J. R. Rojas, R. C. Trievel, J. Zhou, Y. Mo, X. Li, S. L. Berger, C. D. Allis, and R. Marmorstein, Nature 401, 93 (1999).
18. K. Subbaramaiah, P. A. Cole, and A. J. Dannenberg, Cancer Res. 62, 2522 (2002).
19. T. K. Kundu, V. B. Palhan, Z. Y. Wang, W. An, P. A. Cole, and R. G. Roeder, Mol. Cell 6, 551 (2000).
20. W. An, V. B. Palhan, M. A. Karymov, S. H. Leuba, and R. G. Roeder, Mol. Cell 9, 811 (2002).
21. H. Asahara, B. Santoso, K. Du, P. A. Cole, I. Davidson, and M. Montminy, Mol. Cell Biol. 21, 7892 (2001).
22. H. Lu, C. A. Pise-Masison, T. M. Fletcher, R. L. Schiltz, A. Nagaich, M. Radonovich, G. Hager, P. A. Cole, and J. N. Brady, Mol. Cell Biol. 22, 4450 (2002).
23. S. A. Georges, H. A. Giebler, P. A. Cole, K. Luger, P. J. Laybourn, and J. K. Nyborg, Mol. Cell Biol. 23, 3392 (2003).
24. J. Li, K. C. Lee, P. A. Cole, J. Wong, and W. L. Kraus, Mol. Endocrinol. 17, 908 (2003).
25. M. Victor, Y. Bei, F. Gay, D., C. Mello, and Y. Shi, EMBO Rep. 3, 50 (2002).
26. A. Costanzo, P. Merlo, N. Pediconi, M. Fulco, V. Sartorelli, P. A. Cole, G. Fontemaggi, M. Fanciulli, L. Schiltz, G. Blandino, C. Balsano, and M. Levrero, Mol. Cell 9, 175 (2002).
27. K. Kaehlcke, A. Dorr, C. Hetzer-Egger, V. Kiermer, P. Henklein, M. Schnoelzer, E. Loret, P. A. Cole, E. Verdin, and M. Ott, "Acetylation of Tat defines a Cyclin T1-independent step in HIV transactivation." Mol. Cell 12, 167-176 (2003).
28. Z.-Q. Huang, J. Li, L. M. Sachs, P. A. Cole, and J. Wong, EMBO J. 22, 2146 (2003).
29. T. A. McKinsey, C. L. Zhang, and E. N. Olson, Curr. Opin. Cell Biol. 14, 763 (2002).
30. D. Bandyopadhyay, N. A. Okan, E. Bales, L. Nascimento, P. A. Cole, and E. E. Medrano, Cancer Res. 62, 6231 (2002).